Henlius (2696 HK): This Should Trade Tighter. Get Involved

Dec 19, 2024

∙ Paid

After the China Traditional Chinese Medicine (570 HK) fiasco back in October, Hong Kong M&As have (finally) received some welcome Xmas cheer of late.
Small-Cap CM Hi-Tech (2115 HK) secured reg approvals in record time. Then CPMC (906 HK)'s pre-cons were satisfied on 13th December. Now Shanghai Henlius (2696 HK)'s pre-cons are also fulfilled.
Henlius' spread narrowed after securing NDRC approval on the 22nd Nov; and again after fulfilling pre-cons this week. A 3.1% gross spread is okay. This is done. Get involved.

Keep reading with a 7-day free trial

Subscribe to Hong Kong/China M&A/Events to keep reading this post and get 7 days of free access to the full post archives.